|
| Nifedipine |
|
Clostridium |
TcdB (Toxin B) |
In vitro |
|
| Propyl 4-(3-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate |
|
Clostridium |
TcdB (Toxin B) |
In vitro |
|
| Perphenazine |
|
Coxiella
Legionella |
Dot/Icm T4SS
Dot/Icm (Defect in organella trafficking/intracellular multiplication) |
In vitro
In vitro |
|
| Roxindole |
|
Coxiella
Legionella |
Dot/Icm T4SS
Dot/Icm (Defect in organella trafficking/intracellular multiplication) |
In vitro
In vitro |
|
| Piperazinehexanamide derivative, 5 |
|
Coxiella
Legionella |
Dot/Icm T4SS
Dot/Icm (Defect in organella trafficking/intracellular multiplication) |
In vitro
In vitro |
|
| 2',4-Diphenyl-2,4'-(p-phenylene)dithiazole |
|
Enterococcus
Staphylococcus |
Others; Adherence; Biofilm
Others; Adherence; Biofilm |
In vitro
In vitro |
|
| N-[3-(2-amino-1H-imidazol-5-yl)phenyl]-3-cyclopentylpropanamide;hydrochloride |
|
Escherichia |
Biofilm |
In vitro |
|
| N-[3-(2-amino-1H-imidazol-5-yl)phenyl]adamantane-1-carboxamide;hydrochloride |
|
Escherichia |
Biofilm |
In vitro |
|
| 1-[3-(2-amino-1H-imidazol-5-yl)phenyl]-3-(3,4-dichlorophenyl)urea |
|
Francisella |
Regulation |
In vitro |
|
| (4Z)-4-benzylidene-2-phenyl-5-(trifluoromethyl)pyrazol-3-one |
|
Haemophilus |
LOS |
In vitro |
|
| | | |
